36
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Quantitative proteomic analyses reveal that GPX4 downregulation during myocardial infarction contributes to ferroptosis in cardiomyocytes

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Ischaemic heart disease (IHD) is the leading cause of death worldwide. Although myocardial cell death plays a significant role in myocardial infarction (MI), its underlying mechanism remains to be elucidated. To understand the progression of MI and identify potential therapeutic targets, we performed tandem mass tag (TMT)-based quantitative proteomic analysis using an MI mouse model. Gene ontology (GO) analysis and gene set enrichment analysis (GSEA) revealed that the glutathione metabolic pathway and reactive oxygen species (ROS) pathway were significantly downregulated during MI. In particular, glutathione peroxidase 4 (GPX4), which protects cells from ferroptosis (an iron-dependent programme of regulated necrosis), was downregulated in the early and middle stages of MI. RNA-seq and qRT-PCR analyses suggested that GPX4 downregulation occurred at the transcriptional level. Depletion or inhibition of GPX4 using specific siRNA or the chemical inhibitor RSL3, respectively, resulted in the accumulation of lipid peroxide, leading to cell death by ferroptosis in H9c2 cardiomyoblasts. Although neonatal rat ventricular myocytes (NRVMs) were less sensitive to GPX4 inhibition than H9c2 cells, NRVMs rapidly underwent ferroptosis in response to GPX4 inhibition under cysteine deprivation. Our study suggests that downregulation of GPX4 during MI contributes to ferroptotic cell death in cardiomyocytes upon metabolic stress such as cysteine deprivation.

          Related collections

          Most cited references46

          • Record: found
          • Abstract: found
          • Article: not found

          ACSL4 dictates ferroptosis sensitivity by shaping cellular lipid composition.

          Ferroptosis is a form of regulated necrotic cell death controlled by glutathione peroxidase 4 (GPX4). At present, mechanisms that could predict sensitivity and/or resistance and that may be exploited to modulate ferroptosis are needed. We applied two independent approaches-a genome-wide CRISPR-based genetic screen and microarray analysis of ferroptosis-resistant cell lines-to uncover acyl-CoA synthetase long-chain family member 4 (ACSL4) as an essential component for ferroptosis execution. Specifically, Gpx4-Acsl4 double-knockout cells showed marked resistance to ferroptosis. Mechanistically, ACSL4 enriched cellular membranes with long polyunsaturated ω6 fatty acids. Moreover, ACSL4 was preferentially expressed in a panel of basal-like breast cancer cell lines and predicted their sensitivity to ferroptosis. Pharmacological targeting of ACSL4 with thiazolidinediones, a class of antidiabetic compound, ameliorated tissue demise in a mouse model of ferroptosis, suggesting that ACSL4 inhibition is a viable therapeutic approach to preventing ferroptosis-related diseases.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Oxidized arachidonic and adrenic PEs navigate cells to ferroptosis.

            Enigmatic lipid peroxidation products have been claimed as the proximate executioners of ferroptosis-a specialized death program triggered by insufficiency of glutathione peroxidase 4 (GPX4). Using quantitative redox lipidomics, reverse genetics, bioinformatics and systems biology, we discovered that ferroptosis involves a highly organized oxygenation center, wherein oxidation in endoplasmic-reticulum-associated compartments occurs on only one class of phospholipids (phosphatidylethanolamines (PEs)) and is specific toward two fatty acyls-arachidonoyl (AA) and adrenoyl (AdA). Suppression of AA or AdA esterification into PE by genetic or pharmacological inhibition of acyl-CoA synthase 4 (ACSL4) acts as a specific antiferroptotic rescue pathway. Lipoxygenase (LOX) generates doubly and triply-oxygenated (15-hydroperoxy)-diacylated PE species, which act as death signals, and tocopherols and tocotrienols (vitamin E) suppress LOX and protect against ferroptosis, suggesting a homeostatic physiological role for vitamin E. This oxidative PE death pathway may also represent a target for drug discovery.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: found

              Dependency of a therapy-resistant state of cancer cells on a lipid peroxidase pathway

              Plasticity of the cell state has been proposed to drive resistance to multiple classes of cancer therapies, thereby limiting their effectiveness. A high-mesenchymal cell state observed in human tumours and cancer cell lines has been associated with resistance to multiple treatment modalities across diverse cancer lineages, but the mechanistic underpinning for this state has remained incompletely understood. Here we molecularly characterize this therapy-resistant high-mesenchymal cell state in human cancer cell lines and organoids and show that it depends on a druggable lipid-peroxidase pathway that protects against ferroptosis, a non-apoptotic form of cell death induced by the build-up of toxic lipid peroxides. We show that this cell state is characterized by activity of enzymes that promote the synthesis of polyunsaturated lipids. These lipids are the substrates for lipid peroxidation by lipoxygenase enzymes. This lipid metabolism creates a dependency on pathways converging on the phospholipid glutathione peroxidase (GPX4), a selenocysteine-containing enzyme that dissipates lipid peroxides and thereby prevents the iron-mediated reactions of peroxides that induce ferroptotic cell death. Dependency on GPX4 was found to exist across diverse therapy-resistant states characterized by high expression of ZEB1, including epithelial–mesenchymal transition in epithelial-derived carcinomas, TGFβ-mediated therapy-resistance in melanoma, treatment-induced neuroendocrine transdifferentiation in prostate cancer, and sarcomas, which are fixed in a mesenchymal state owing to their cells of origin. We identify vulnerability to ferroptic cell death induced by inhibition of a lipid peroxidase pathway as a feature of therapy-resistant cancer cells across diverse mesenchymal cell-state contexts.
                Bookmark

                Author and article information

                Contributors
                dhkim@gist.ac.kr
                ewlee@kribb.re.kr
                lesach@kribb.re.kr
                Journal
                Cell Death Dis
                Cell Death Dis
                Cell Death & Disease
                Nature Publishing Group UK (London )
                2041-4889
                4 November 2019
                4 November 2019
                November 2019
                : 10
                : 11
                : 835
                Affiliations
                [1 ]ISNI 0000 0004 0636 3099, GRID grid.249967.7, Metabolic Regulation Research Center, , Korea Research Institute of Bioscience and Biotechnology (KRIBB), ; Daejeon, 34141 Korea
                [2 ]ISNI 0000 0001 0722 6377, GRID grid.254230.2, Department of Microbiology and Molecular Biology, College of Bioscience and Biotechnology, , Chungnam National University, ; Daejeon, 34134 Korea
                [3 ]ISNI 0000 0001 1033 9831, GRID grid.61221.36, School of Life Sciences and Systems Biology Research Center, , Gwangju Institute of Science and Technology (GIST), ; Gwangju, 61005 Korea
                [4 ]ISNI 0000 0004 0636 3099, GRID grid.249967.7, Disease Target Structure Research Center, , Korea Research Institute of Bioscience and Biotechnology (KRIBB), ; Daejeon, 34141 Korea
                [5 ]ISNI 0000 0001 2292 0500, GRID grid.37172.30, Department of Biological Sciences, , Korea Advanced Institute of Science and Technology (KAIST), ; Daejeon, 34141 Korea
                [6 ]ISNI 0000 0004 1791 8264, GRID grid.412786.e, Department of Functional Genomics, , University of Science and Technology (UST), ; Daejeon, 34141 Korea
                [7 ]ISNI 0000 0004 0647 2471, GRID grid.411597.f, Department of Cardiology, , Chonnam National University Hospital, ; Gwangju, Korea
                [8 ]ISNI 0000 0004 0470 5454, GRID grid.15444.30, Department of Biochemistry, College of Life Science and Biotechnology, , Yonsei University, ; Seoul, 03722 Korea
                Author information
                http://orcid.org/0000-0002-5156-0003
                Article
                2061
                10.1038/s41419-019-2061-8
                6828761
                31685805
                fea4cffb-2ca1-4d62-8e8f-5904ed4c418d
                © The Author(s) 2019

                Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.

                History
                : 2 April 2019
                : 5 August 2019
                : 23 September 2019
                Funding
                Funded by: FundRef https://doi.org/10.13039/501100003725, National Research Foundation of Korea (NRF);
                Award ID: 2019R1C1C1002831
                Award ID: 2015M3A9D7029882
                Award Recipient :
                Funded by: FundRef https://doi.org/10.13039/501100003715, Korea Research Institute of Bioscience and Biotechnology (KRIBB);
                Categories
                Article
                Custom metadata
                © The Author(s) 2019

                Cell biology
                protein-protein interaction networks,necroptosis,heart failure
                Cell biology
                protein-protein interaction networks, necroptosis, heart failure

                Comments

                Comment on this article